Scoop has an Ethical Paywall
Pfizer seeks to acquire Hospira
Statement of preliminary issues for Pfizer’s application to acquire Hospira
The Commerce Commission has
published a statement of preliminary issues relating to an
application from Pfizer to acquire all of the remaining
shares in Hospira.
Pfizer and Hospira are both global companies that manufacture and supply pharmaceutical products.
The statement of preliminary issues outlines the key competition issues that the Commission currently considers will be important in deciding whether or not to grant clearance.
The Commission invites submissions from parties who consider that they have information relevant to the Commission’s consideration of this matter.
Submissions can be sent by email to registrar@comcom.govt.nz with the reference Pfizer / Hospira in the subject line, or by mail to PO Box 2351, Wellington 6140. Any submissions should be received by close of business 29 May 2015.
The statement of preliminary issues and a public version of the application can be found on the Commission’s Clearances Register which is accessible through our website.
ends
Business Canterbury: Urges Council To Cut Costs, Not Ambition For City
Wellington Airport: On Track For Net Zero Emissions By 2028
Landcare Research: ANZAC Gall Fly Release Promises Natural Solution To Weed Threat
NZ Anti-Vivisection Society: Auckland Rat Lovers Unite!
University of Canterbury: $1.35 Million Grant To Study Lion-like Jumping Spiders
Federated Farmers: Government Ends War On Farming
